Biostar Pharmaceuticals, Inc. (BSPM)

[Michael Anderson]

The growing cash is great. Also, thinking down the road, I wouldnt be surprised to see that cash grow to near $50 million by the end of 2011. I hope they slowly start making more acquisitions. This coming year should be interesting for them. If they can start producing raw materials for sale, that will be huge as well. So there are definitely some good prospects coming up for the company and expansion into other areas.